ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NTRA vs CI // GROSS PROFIT MARGIN

Natera Inc. (NASDAQ) VS. The Cigna Group (NYSE) • 15-METRIC TALLY: NTRA 5 — CI 7
■ METRIC PARITY
gross-margins
—
gross-margins
21.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTRA VS. CI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NTRA CI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 21.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -4.90% 8.80% -13.70 CI /roic <GO>
EV/EBITDA & P/E Valuation — 6.1x — TIE /valuation <GO>
Free Cash Flow Yield 0.17% -3.51% +3.68 NTRA /fcf-yield <GO>
Operating Margin -13.40% 3.30% -16.70 CI /operating-margins <GO>
Net Profit Margin -9.00% 2.20% -11.20 CI /net-margins <GO>
Revenue Growth (YoY) 35.90% 11.20% +24.70 NTRA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.04% -2.04 CI /dividend-safety <GO>
Altman Z-Score & Debt/Equity 26.00 2.70 +23.30 NTRA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 5/9 +2.00 NTRA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 64.0 55.8 +8.20 NTRA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.09 1.12 -0.03 CI /macro-sensitivity <GO>
Forward P/E Multiple 18.0x 12.3x +5.70 CI /forward-pe <GO>
Enterprise Scale & Market Cap $62.85B $78.85B -$16.01B CI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NTRA REV CI REV NTRA GROSS % CI GROSS % NTRA FCF CI FCF
FY 2025 $2.31B $274.90B — 21.8% $109.1M -$2.77B
FY 2024 $1.70B $247.12B — 26.1% $69.2M -$757.4M
FY 2023 $1.08B $195.26B — — -$295.7M $3.03B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTRA // BETA 1.09
CI // BETA 1.12